Kymera Therapeutics Clears Key Benchmark, Hitting 80-Plus RS Rating

Investor's Business Daily provides a rating from 1 to 99, indicating a stock's share price movement compared to others in their database. Stocks with an RS rating of 80 or higher tend to perform well historically.